UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

Journal of neuro-oncology, 2021-03, Vol.152 (1), p.47-54

2021

Volltextzugriff (PDF)

Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

International journal of clinical oncology, 2021-08, Vol.26 (8), p.1441-1449

2021

Volltextzugriff (PDF)

Learning by teaching technological knowledge: conceptual skill development in Japanese overseas subsidiaries

SN Business & Economics, 2022-08, Vol.2 (9), Article 125

2022

Volltextzugriff (PDF)

Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

Cancers, 2021-02, Vol.13 (4), p.758

2021

Volltextzugriff (PDF)

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid

Cancers, 2024-02, Vol.16 (5), p.1009

2024

Volltextzugriff (PDF)

A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient

Neuropathology, 2020-02, Vol.40 (1), p.99-103

2020

Volltextzugriff (PDF)

Clinical implications of molecular analysis in diffuse glioma stratification

Brain tumor pathology, 2021-07, Vol.38 (3), p.210-217

2021

Volltextzugriff (PDF)

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3177-3187

2021

Volltextzugriff (PDF)

A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient

Neuropathology, 2022-06, Vol.42 (3), p.197-203

2022

Volltextzugriff (PDF)

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma

Pharmaceuticals (Basel, Switzerland), 2020-12, Vol.13 (12), p.470

2020

Volltextzugriff (PDF)

CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma

Frontiers in immunology, 2021-06, Vol.12, p.670131-670131

2021

Volltextzugriff (PDF)

Time-of-flight MRA signal intensity predicts the cerebral hemodynamic status after superficial temporal artery to middle cerebral artery anastomosis

Journal of clinical neuroscience, 2019-01, Vol.59, p.124-129

2019

Volltextzugriff (PDF)

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification

Clinical neurology and neurosurgery, 2019-12, Vol.187, p.105556-105556, Article 105556

2019

Volltextzugriff (PDF)

A juvenile case of epilepsy‐associated, isocitrate dehydrogenase wild‐type/histone 3 wild‐type diffuse glioma with a rare BRAF A598T mutation

Neuropathology, 2020-12, Vol.40 (6), p.646-650

2020

Volltextzugriff (PDF)

International horizontal transfer of production technology systems: Case studies on the effect that providing technological training have on engineers and operators

Journal of International Business, 2020, Vol.12(2), pp.19-33

FUJIOKA, Yutaka

2020

Volltextzugriff (PDF)

Correction to: Cortical high‑flow sign on arterial spin labeling: a novel biomarker for IDH‑mutation and 1p/19q‑codeletion status in diffuse gliomas without intense contrast enhancement

Neuroradiology, 2023-11, Vol.65 (11), p.1675-1676

2023

Volltextzugriff (PDF)

PATH-28. OUTCOME IMPACT OF THE CDKN2A/B HEMI -ZYGOUS DELETION IN IDH-MUTANT ASTROCYTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v173-v174

2023

Volltextzugriff (PDF)

In-house molecular diagnosis of diffuse glioma updating the revised WHO classification by a platform of the advanced medical care system, Senshin-Iryo

Neuropathology, 2024-03

2024

Volltextzugriff (PDF)

GCT-16. LONG-TERM OUTCOMES AND COMPLICATION MANAGEMENT IN CNS GERM CELL TUMORS: INSIGHTS FROM A PHASE II HISTOPATHOLOGY-STRATIFIED TREATMENT TRIAL

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

A case of metastatic brain tumor mimicking an expanding thalamic hematoma

Surgical neurology international, 2019-01, Vol.10 (1), p.3-3

2019

Volltextzugriff (PDF)

生産技術システムの国際水平移転: 教えることの効果に関する事例研究

国際ビジネス研究, 2020, Vol.12(2), pp.19-33

藤岡, 豊

2020

Volltextzugriff (PDF)

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii468-iii468

2020

Volltextzugriff (PDF)

Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae069

2024

Volltextzugriff (PDF)

Historical and Modern Features for Buddha Statue Classification

Proceedings of the 1st Workshop on Structuring and Understanding of Multimedia heritAge Contents, 2019, p.23-30

2019

Volltextzugriff (PDF)

10098-MPC-10 HOW SHOULD WE RESPOND TO REPEATED WHO REVISIONS? IN-HOUSE MOLECULAR DIAGNOSIS SYSTEM BY ADVANCED MEDICAL SYSTEM

Neuro-oncology advances, 2023-12, Vol.5 (Supplement_5), p.v11-v12

2023

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Zeitschrift / SerieNeurologia Medico-Chirurgica

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Englisch
(152)
Japanisch
(75)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cheminform
(11)
Blood
(7)
Angewandte Chemie
(6)
Neuro-Oncology Advances
(6)
Experimental Hematology
(4)
Neuropathology
(4)
Progress Of Theoretical And Experimental Physics
(4)
Tetrahedron Letters
(4)
Modern Rheumatology
(3)
Neuro-Oncology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

Learning by teaching technological knowledge: conceptual skill development in Japanese overseas subsidiaries

Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid

A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient

Clinical implications of molecular analysis in diffuse glioma stratification

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma

CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma

Time-of-flight MRA signal intensity predicts the cerebral hemodynamic status after superficial temporal artery to middle cerebral artery anastomosis

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification

A juvenile case of epilepsy‐associated, isocitrate dehydrogenase wild‐type/histone 3 wild‐type diffuse glioma with a rare BRAF A598T mutation

International horizontal transfer of production technology systems: Case studies on the effect that providing technological training have on engineers and operators

Correction to: Cortical high‑flow sign on arterial spin labeling: a novel biomarker for IDH‑mutation and 1p/19q‑codeletion status in diffuse gliomas without intense contrast enhancement

PATH-28. OUTCOME IMPACT OF THE CDKN2A/B HEMI -ZYGOUS DELETION IN IDH-MUTANT ASTROCYTOMA

In-house molecular diagnosis of diffuse glioma updating the revised WHO classification by a platform of the advanced medical care system, Senshin-Iryo

GCT-16. LONG-TERM OUTCOMES AND COMPLICATION MANAGEMENT IN CNS GERM CELL TUMORS: INSIGHTS FROM A PHASE II HISTOPATHOLOGY-STRATIFIED TREATMENT TRIAL

A case of metastatic brain tumor mimicking an expanding thalamic hematoma

生産技術システムの国際水平移転: 教えることの効果に関する事例研究

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS

Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma

Historical and Modern Features for Buddha Statue Classification

10098-MPC-10 HOW SHOULD WE RESPOND TO REPEATED WHO REVISIONS? IN-HOUSE MOLECULAR DIAGNOSIS SYSTEM BY ADVANCED MEDICAL SYSTEM

Aktive Filter

Suchergebnisse filtern